Lv4
618 积分 2022-07-23 加入
Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial
1天前
待确认
The changing therapeutic landscape of small-cell lung cancer
1天前
已完结
Registration-guided GAN Synthesis of Virtual Contrast-enhanced Thoracic CT for Hilar and Mediastinal Lymph Node Detection
2天前
已关闭
Tobacco Treatment in the Inpatient Setting: An American College of Chest Physicians Clinical Practice Guideline
3天前
已完结
Lymph Node Pathologic Grading Strategy: under the backdrop of the IASLC Grading System for Invasive Lung Adenocarcinoma - a retrospective cohort study among Asian patients
3天前
已完结
Consensus on standardized later-line systemic therapy for hepatocellular carcinoma
6天前
已完结
The decade that changed hepatocellular carcinoma: shaping a new treatment paradigm
6天前
已完结
Conversion surgery as a missing outcome in first-line immunotherapy trials for hepatocellular carcinoma
6天前
已完结
On-demand transarterial chemoembolisation combined with atezolizumab and bevacizumab in patients with untreated hepatocellular carcinoma (TALENTACE): a multicentre, randomised, open-label, phase 3 trial
6天前
已完结
Survival after pathological complete response following neoadjuvant chemotherapy versus chemoradiotherapy for oesophageal squamous cell carcinoma
14天前
已完结
皖公网安备34019202002308
